Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone

Biochemical and Biophysical Research Communications
T W DoebberT Y Shen


Evidence from three types of experiments indicates that platelet activating factor (PAF)1 is an important mediator of endotoxin-induced hypotension in rats. a) Endotoxin infusion stimulates the time-dependent appearance of PAF in the blood. b) PAF infusion results immediately (less than 30 sec) in hypotension while endotoxin-induced hypotension takes 3-5 min to occur, allowing time for PAF production. c) Infusion of the specific PAF-receptor antagonist kadsurenone (2.2 mumole/kg bolus, 0.9 mumoles/min/kg continuous infusion), which inhibits PAF-induced hypotension by 67%, causes a 67% reversal of endotoxin-elicited hypotension. An additional finding of this study is that rats respond hypotensively to each of a series of low-dose PAF infusions but only to the first low-dose endotoxin infusion. These endotoxin-refractory rats do respond to subsequent PAF infusions.


Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·I LemaireS Lemaire


Feb 1, 1988·Digestive Diseases and Sciences·J L Wallace, B J Whittle
Dec 1, 1991·Lipids·R RabinoviciG Z Feuerstein
Jan 1, 1986·Immunologic Research·B Beutler, A Cerami
Jan 18, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Chin-Wei ChiaoMing-Jai Su
May 28, 1992·Biochemical Pharmacology·B KlosterhalfenP C Heinrich
Jan 3, 1991·European Journal of Pharmacology·F SquadritoA P Caputi
Dec 17, 1991·European Journal of Pharmacology·A KleeD Seiffge
Oct 1, 1992·Toxicon : Official Journal of the International Society on Toxinology·A YaraM Sakanashi
Jul 1, 1986·Prostaglandins·J L Wallace, B J Whittle
Mar 1, 1994·Prostaglandins·D L KaminskiY G Deshpande
Jan 1, 1988·Molecular Aspects of Medicine·N C OlsonC E McCall
Aug 1, 1989·Molecular Immunology·M A SmalJ W Redmond
Sep 1, 1990·Immunopharmacology·H A LeaverP L Yap
Aug 1, 1994·Pharmacology & Therapeutics·S P Travis, D P Jewell
Jan 1, 1993·International Journal of Antimicrobial Agents·S Q DejoyS S Kerwar
Jan 31, 1989·Biochemical and Biophysical Research Communications·J G FilepT Mózes
Apr 23, 1997·European Journal of Pharmacology·D H AlbertG W Carter
May 22, 1998·General Pharmacology·B Klosterhalfen, R S Bhardwaj
Apr 12, 2001·Journal of Ethnopharmacology·Ibrahim JantanN A Warif
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D M StafforiniS M Prescott
Aug 1, 1986·The Journal of Cell Biology·G W Conrad, T J Rink
Jun 1, 1995·Clinical and Experimental Pharmacology & Physiology·J F ArthurG J Dusting
Sep 1, 1992·Journal of Gastroenterology and Hepatology·S KitagawaK Inoue
Dec 1, 1993·British Journal of Pharmacology·J G Filep, E Földes-Filep
Oct 1, 1987·Journal of Veterinary Internal Medicine·D D Morris, R H Whitlock
Feb 26, 1998·American Journal of Respiratory Cell and Molecular Biology·J M MiotlaP G Hellewell
May 1, 1987·The Journal of Clinical Investigation·S W ChangN F Voelkel
May 1, 1989·The Journal of Clinical Investigation·F Lopez DiezM Sanchez Crespo
Jul 1, 1989·The Journal of Clinical Investigation·E A DeitchR D Berg
Jun 1, 1994·The Journal of Clinical Investigation·G AmbrosioM Triggiani
Nov 1, 1996·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·R RibeiroE Tibiriçá
May 27, 2016·Temperature : Multidisciplinary Biomedical Journal·Alexandre A Steiner, Andrej A Romanovsky
Oct 21, 2003·The Journal of Physiology·Andrei I IvanovAndrej A Romanovsky
May 3, 2005·Biochimica Et Biophysica Acta·John S OwenRobert L Wykle
Feb 8, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Ibrahim JantanJuriyati Jalil
Jan 15, 1992·Thrombosis Research·K SawadaT Abe
Dec 1, 1989·Resuscitation·D HosfordP Braquet
Jul 1, 1988·Thrombosis Research·J G GarciaA R Johnson
Nov 1, 1991·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J SugataniK Saito
Dec 1, 1990·Clinical Immunology and Immunopathology·G CamussiC Baglioni
Jun 10, 1998·Toxicon : Official Journal of the International Society on Toxinology·D V TambourgiW Dias Da Silva
Sep 1, 1990·Journal of Veterinary Internal Medicine·E M Hardie, K Kruse-Elliott
Feb 15, 2001·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·Shigeru IwazakiYasuo Morishita
Aug 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P M KochanekD F Burke
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S B MustafaM S Olson
Jan 31, 2014·The Journal of Biological Chemistry·Johanna RiveraDavid L Goldman
Apr 1, 1989·Medicinal Research Reviews·K H Weber, H O Heuer
Jun 12, 1995·Annals of the New York Academy of Sciences·G LázárM K Agarwal
Nov 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F GuarnerJ Rodés
Mar 3, 2005·Phytotherapy Research : PTR·Ibrahim JantanJuriyati Jalil
Apr 1, 1989·Biomedical & Environmental Mass Spectrometry·B W Christman, I A Blair
May 1, 1991·Journal of Veterinary Internal Medicine·D D Morris
Feb 12, 1987·The New England Journal of Medicine·B Beutler, A Cerami
Oct 4, 2000·Physiological Reviews·G MontrucchioG Camussi
Feb 1, 1988·The American Journal of Physiology·C H LangJ J Spitzer
Mar 1, 1988·American Journal of Reproductive Immunology and Microbiology : AJRIM·J A McGregorJ K Todd
Dec 1, 1991·Lipids·R E GoldsteinN J Davenport
Jan 4, 1988·FEBS Letters·J BenvenisteJ C Fruchart
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·U Pattanaik, K Prasad
Aug 1, 1989·European Journal of Haematology·N H WhitworthP Dandona
Jan 1, 1991·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·S B FelixW E Berdel
Sep 1, 1987·British Journal of Pharmacology·B J WhittleJ L Wallace
Feb 7, 2002·Cardiovascular Drug Reviews·E Tibiriçá

Related Concepts

Platelet activating factor receptor
Kadsurenone, (2S-(2alpha,3beta,3abeta))-isomer
Alkalescens-Dispar Group
Platelet Activating Factor
Platelet Membrane Glycoproteins

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.